NASDAQ · Medical - Healthcare Information Services

Akerna Corp. (KERN) Stock

$0.31 +36.94% NASDAQ: KERN Healthcare

Akerna Corp., a Denver, Colorado-based company established in 2010, develops and provides sophisticated enterprise software solutions. These solutions primarily cater to businesses in the United States and Canada, enabling robust regulatory compliance and efficient inventory management.

Valuation

MetricValue
Price$0.31
Market Cap$162320
P/E Ratio-2.20
P/B Ratio0.46
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$20.40
52-Week Low$0.25
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-16.65%
ROA-6.15%
ROCE-6.99%
Gross Margin52.92%
Operating Margin-65.94%
Net Margin-63.39%
Debt/Equity0.29
Current Ratio0.13

Annual Financials (USD)

Metric20192021202220242025
Revenue$11.0M$21.0M$14.0M$21.0M$0
Operating Profit$-12.0M$-19.0M$-16.0M$-18.0M$0
Net Profit$-12.0M$-34.0M$-59.0M$-21.0M$0
EPS$-40.71$-26.18$-20.02$-0.51$0.00
Op Margin-113.7%-91.7%-120.8%-86.4%-123.1%

Balance Sheet (USD)

Metric20192021202220242025
Total Assets$25.0M$92.0M$19.0M$0$1.2B
Total Liabilities$2.0M$35.0M$24.0M$0$581.0M
Cash$22.0M$14.0M$1.0M$0$4.0M
Borrowings$16.0M$17.0M$15.0M$0$188.0M

Cash Flow (USD)

Metric20192021202220242025
Operating Cash Flow$-9.0M$-8.0M$-11.0M$-3.0M$-80.0M
Investing Cash Flow$16.0M$-16.0M$-8.0M$-3.0M$-398.0M
Financing Cash Flow$0$17.0M$-1.0M$6.0M$482.0M
Net Cash Flow$20.0M$-4.0M$-6.0M$0$4.0M
Free Cash Flow$-12.0M$-13.0M$-15.0M$-3.0M$-80.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.02
EV / EBITDA-6.85
FCF Yield-76971.57%
Quick Ratio0.13
Interest Coverage13893.33
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATLN $0.90 +0.00% -1.31 $73.17M 0.00%
BLPHBellerophon Therapeutics, Inc. $0.01 -36.84% -0.01 $146791 0.00%
CMAXCareMax, Inc. $0.42 +100.00% 0.00 $1.61M 0.00%
HSTOHistogen Inc. $0.02 — -0.01 $85435 0.00%
HUGEFSD Pharma Inc. $0.09 -10.10% -0.19 $66671 0.00%

About Akerna Corp.

Akerna Corp., a Denver, Colorado-based company established in 2010, develops and provides sophisticated enterprise software solutions. These solutions primarily cater to businesses in the United States and Canada, enabling robust regulatory compliance and efficient inventory management. Their product portfolio includes MJ Platform, specifically designed for the burgeoning cannabis, hemp, and CBD industries, and Leaf Data Systems, a dedicated regulatory software for government agencies. A cornerstone of their offerings is a comprehensive "seed-to-sale" platform. This technology furnishes cultivators, processors, retailers, and clinics within the cannabis sector with essential tools for tracking, reporting, and maintaining compliance throughout the entire supply chain, extending to what they term 'seed-to-sale-to-self' data. Akerna further extends its expertise through consulting services for the cannabis industry, alongside offerings in business intelligence, data analytics, and other software-related support. Additionally, they offer Last Call Analytics, a distinct tool that assists alcohol brands in scrutinizing their retail sales performance.

Akerna Corp. is headquartered in US.

Akerna Corp. (KERN) stock trades at $0.31 with a market capitalization of $162320. The stock is valued at a price-to-earnings (P/E) ratio of -2.20, price-to-book of 0.46, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.25 and $20.40, and currently trades 98.5% below its 52-week high.

On profitability, Akerna Corp. generates a return on equity (ROE) of -16.65%, return on capital employed of -6.99%, an operating margin of -65.94%, a net profit margin of -63.39%.

Official website: www.akerna.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides